Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call presents mixed signals: stable financial performance with revenue within guidance and slight margin improvement, yet challenges in operating efficiency and geopolitical dynamics. The Q&A reveals cautious expansion in India and unclear strategies for macroeconomic pressures. Despite a positive shareholder return plan, the company's strategic ambiguity and modest financial outlook suggest a neutral market reaction.
Key Financial Performance
Revenue $320.6 million, within the guidance range, including a 1% favorable foreign currency impact.
GAAP earnings per share $0.04
Adjusted earnings per share $0.14, excluding costs related to the decision to wind down the separate BeautyBio business and other charges.
Adjusted gross margin 67.9%, compared to 67.8% in the prior year, reflecting a relatively stable revenue mix between the Nu Skin core and RISE entities.
Core Nu Skin business gross margin 76.9%, up 20 basis points from the prior year, reflecting continued progress in operational efficiency initiatives and product mix optimization.
Consolidated selling expense 34.3% of revenue, compared to 32.5% in the prior year.
Core Nu Skin business selling expense 40.5%, up from 38.7% in the prior year, consistent with expectations as focus continues on rewarding sales leaders' productivity through compensation plan enhancements.
General and administrative expenses Declined by $9 million year-over-year on an adjusted basis, reflecting continued cost discipline while focusing on future investments. As a percentage of revenue, G&A was 29.9%, up from 28.9% in the prior year, reflecting ongoing investments in technology and emerging market expansion, including India.
Adjusted operating margin 3.6%, down from 6.4% in the prior year.
Debt refinancing Completed a refinancing of credit facilities, extending maturities through 2031 and improving the overall cost of borrowing.
Shareholder returns Approximately $8 million returned to shareholders during the quarter, comprised of $3 million in dividends and $5 million in share repurchases.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Prysm iO: Introduced as a foundational platform for personalized wellness assessments. Generated nearly 2 million scans globally since December, with 30,000 devices in use. Subscription volume increased by 5% year-over-year, and flagship LifePak brand grew over 10%.
Tru Face anti-aging product: Rolled out in Mainland China, showing growing leader engagement.
Emerging markets expansion: Focused on Latin America, Southeast Asia, China, and India. Latin America showed sustained growth, and India is in pre-market entry phase with a formal launch planned by the end of the year.
Operational efficiency: Improved gross margin to 67.9% through localized manufacturing, portfolio optimization, and strategic pricing. Reduced G&A expenses by $9 million year-over-year.
Selling expense: Increased to 40.5% of revenue in the core business to reward sales leaders' productivity.
Intelligent Beauty and Wellness platform: Centered around Prysm iO and AI integration for personalized insights and product recommendations. Positioned as a long-term growth driver.
Market positioning: Transitioning sales leaders from social sellers to Beauty and Wellness consultants to align with the Prysm iO platform.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Macroeconomic Pressures: Uncertain macroeconomic conditions are impacting consumers and supply chains globally, creating challenges for the company's operations and growth.
Regional Market Pressures: Certain reporting segments are under pressure due to broader macroeconomic and industry dynamics, which could hinder regional performance.
Adoption of New Platform (Prysm iO): The transition to the Prysm iO platform involves near-term switching costs, requiring training, behavior change, and market education, which could delay adoption and impact short-term performance.
Emerging Market Expansion: Expanding into developing and emerging markets like India and Southeast Asia presents challenges in balancing premium brand positioning with localized needs and infrastructure setup.
Operating Efficiency: Sustaining growth in gross margin is challenged by uncertain trade practices and inflationary pressures, including tariffs and fuel price increases.
Sales Compensation Structure: Adjustments to sales compensation structures to align with local entrepreneurial segments may create short-term financial strain.
Geopolitical Dynamics: Broader geopolitical dynamics could impact consumer sentiment and operational stability.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Guidance for Q2 2026: Expected revenue in the range of $330 million to $360 million, reflecting sequential improvement from Q1 2026.
Earnings Per Share (EPS) Guidance for Q2 2026: Expected EPS in the range of $0.15 to $0.25, reflecting sequential improvement.
Annual Guidance for 2026: Maintaining annual guidance with more clarity to be provided following Q2 2026.
Emerging Market Expansion: Continued investment in emerging markets, including India, with a formal launch planned by the end of 2026.
Prysm iO Adoption and Growth: Anticipated increase in subscriptions and customer lifetime value as Prysm iO adoption grows. Future platform updates to include deeper AI-driven insights.
Gross Margin Improvement: Focus on sustaining and improving gross margin through localized manufacturing, portfolio optimization, and strategic pricing actions.
Operating Efficiency: Commitment to aligning cost structure with revenue while investing in growth initiatives.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Dividends paid in Q1 2026: $3 million
Remaining share repurchase authorization: $137.3 million
Share repurchases in Q1 2026: $5 million
Remaining share repurchase authorization: $137.3 million
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What are the qualities of a successful leader in Prysm, and how is training tailored to help them succeed?
A:Successful leaders in Prysm utilize it as a wellness consultative or assessment tool. Training focuses on product knowledge (carotenoid measurement and antioxidant benefits), consumer journey knowledge (scanning, learning, and product subscription), and CRM skills (customer follow-up and persistency). Additionally, there is a 'train the trainer' approach with certifications in multiple markets, primarily in Asia, to share best practices.
Q:How aggressive is the company in growing its presence in India, and what is the growth potential there?
A:India is considered a very important mid- to long-term market. The direct selling industry in India is relatively small but the fastest growing. The company is taking a cautious approach with a premarket entry phase to learn about the Indian consumer and entrepreneur. Efforts include aligning manufacturing, quality, logistics, distribution, and product formulas. Revenue expectations are low for now, with growth anticipated to ramp up year-by-year starting in 2026.
Q:Where does the company see the most leverage amidst macroeconomic headwinds, and how are they addressing these challenges?
A:The company acknowledges significant macroeconomic pressures, including inflation (16%-30% on consumer goods) and rising fuel costs. They aim to innovate by providing greater value through digital solutions and efficacious Beauty and Wellness formulas. While not anticipating a significant immediate impact, they are monitoring oil prices and other pressures, optimizing gross margins, and preparing mitigation plans.
Q:How is the company prioritizing capital allocation, and what are their plans for debt, M&A, and shareholder returns?
A:The company prioritizes funding the business and investing in strategic opportunities to provide value for customers and sales leaders. They maintain a strong liquidity profile, recently refinanced debt to extend liquidity through 2031, and aim to pay down debt. They also look for opportunities to return value to shareholders through dividends and share repurchases.
Q:Review of Unclear Management Responses
A:Management avoided providing specific revenue forecasts or detailed timelines for growth in India, citing the need for further learning and adjustments. Additionally, while they acknowledged macroeconomic pressures, their responses lacked precise strategies or quantifiable measures to address these challenges.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AI Intelligent
AI scoring
Africa sale
America Southeast
America improvement
Beauty Wellness
Lantz
Today
Treasurer Investor
Wellness platform
behavior
biomarker
community
confidence
discipline
driver
dynamic
ecosystem
engagement
entrepreneur world
experience
fitness
future
household
iO
indicator
introduction
learning
market Latin
need
opportunity reach
product recommendation
product sale
product solution
science product
set
spite
structure
supplementation
tool
wellness assessment
NUS Transcript
Nu Skin Enterprises, Inc. (NUS) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call presents mixed signals: stable financial performance with revenue within guidance and slight margin improvement, yet challenges in operating efficiency and geopolitical dynamics. The Q&A reveals cautious expansion in India and unclear strategies for macroeconomic pressures. Despite a positive shareholder return plan, the company's strategic ambiguity and modest financial outlook suggest a neutral market reaction.
Nu Skin Enterprises, Inc. (NUS) Q4 2025 Earnings Call Transcript
Unknown2-12
The earnings call reflects a mix of positive and negative factors. Positive aspects include a strong EPS growth for 2025, strategic initiatives like Prysm iO, and expansion into India. However, the lack of concrete guidance for Prysm and India, coupled with foreign currency headwinds and cautious 2026 guidance, tempers enthusiasm. The Q&A section reveals management's conservative stance and limited clarity on future revenue contributions. Given these mixed signals and the absence of significant market cap data, a neutral stock price reaction is likely over the next two weeks.
Nu Skin Enterprises, Inc. (NUS) Q3 2025 Earnings Call Transcript
Positive11-7
The earnings call highlights strong financial performance, with EPS at the high end of guidance and improved margins. The company is expanding into India and enhancing product offerings, indicating growth potential. Despite challenges like foreign currency headwinds and supply chain issues, the strategic initiatives, especially the Prysm iO launch and market expansion, suggest a positive outlook. Shareholder returns through dividends and buybacks further support this sentiment. The Q&A section reveals cautious optimism, with management addressing market entry strategies and growth in Southeast Asia, reinforcing a positive sentiment.
Nu Skin Enterprises, Inc. (NUS) Q2 2025 Earnings Call Transcript
Positive8-7
The earnings call reveals strong financial performance with EPS significantly above guidance, improved operational efficiencies, and a strategic focus on expanding in high-growth markets like Latin America and India. Despite macroeconomic challenges in key regions, optimistic guidance and strategic initiatives like Prysm iO suggest potential growth. The absence of share repurchases is offset by dividend payments, and the company's positive cash flow signals financial health. These factors, combined with optimistic guidance and strategic market expansion, indicate a positive stock price movement in the short term.
NUS Slides
Nu Skin Q1 2026 slides: revenue drops 12% as customer base shrinks2026-05-07
Nu Skin Q4 2025 slides: Revenue declines across regions as margins improve2026-02-12
Nu Skin Q2 2025 slides: Revenue declines persist despite operational improvements2025-08-07
Nu Skin Q1 2025 slides: Revenue declines 12.7%, outlook remains cautious2025-05-08
NUS Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
